Cyclospora Outbreak 2026: What Physicians Should Watch for in Persistent GI Symptoms

Introduction

If a patient has walked into your office in the past few months with watery diarrhea that just won't quit, you're not imagining that you're seeing more of this than usual. The United States is in the middle of the largest cyclosporiasis outbreak on record, and it's still active. For physicians, this isn't just a public health headline. It's a real diagnostic trap, because the parasite responsible, Cyclospora cayetanensis, is one of the more commonly missed causes of persistent GI illness precisely because standard stool testing doesn't reliably catch it without a specific order.

This article walks through how big this outbreak actually is, what's driving it, how to recognize cyclosporiasis clinically, why it gets missed, how to test and treat it correctly, and how to code and report it so the diagnosis doesn't just help the patient in front of you but also feeds the public health response tracking this outbreak in real time.

How Large Is the 2026 Cyclospora Outbreak

The scale of this year's outbreak is genuinely unusual, not just a modest seasonal uptick.

1. Since May 1, 2026, the CDC has confirmed more than 15,700 laboratory-confirmed domestic cases of cyclosporiasis, with an additional 11,800 cases still under investigation.
2. For comparison, only about 1,180 cases were reported in the same period in 2025, meaning this year's confirmed case count is running more than ten times higher.
3. A large multistate cluster tied to contaminated iceberg lettuce has affected at least 17 states, with more than 9,400 confirmed cases linked to that specific outbreak alone.
4. Michigan has been hit hardest by far, with more than 13,900 reported cases statewide, over 300 hospitalizations, and two deaths, both in patients with significant underlying health conditions.
5. Cyclosporiasis is a nationally notifiable disease, reportable in 47 states, the District of Columbia, and New York City.

CDC has issued a formal Health Alert Network notice specifically because case counts are outpacing prior years so significantly, and the notice specifically flags that Cyclospora is often missed on standard laboratory panels, which is exactly the clinical issue this article focuses on.

What's Behind This Outbreak

Epidemiologic and traceback investigation identified shredded iceberg lettuce processed by Taylor Farms de Mexico, sourced from a central Mexico grower, as contaminated and responsible for a significant portion of this year's cases. The lettuce was distributed to food service locations, including Taco Bell restaurants, across multiple states, and Taylor Farms issued a voluntary recall of all iceberg lettuce sourced from central Mexico on July 17, 2026.

It's worth noting for clinical purposes that CDC and FDA are simultaneously investigating several other Cyclospora clusters unrelated to the lettuce outbreak, meaning a patient with cyclosporiasis in your office may not have any connection to the recalled product at all. Fresh produce eaten raw, including berries, herbs like basil and cilantro, leafy greens, and snow peas, has historically been the most common vehicle for this parasite in U.S. outbreaks, and that broader pattern still applies even as this specific lettuce-linked cluster gets most of the national attention.

Recognizing Cyclosporiasis in Patients With Persistent GI Symptoms

Cyclospora infection has a clinical presentation that's easy to lump in with routine viral gastroenteritis, especially early on, which is part of why it gets missed.

Typical symptoms

1. Watery diarrhea, often frequent and described by patients as severe or explosive
2. Loss of appetite
3. Unintentional weight loss
4. Bloating and increased gas
5. Nausea
6. Fatigue
7. Low-grade fever, less commonly
8. Vomiting, less commonly

Timing that should raise suspicion

Symptoms typically begin about a week after exposure, with a documented range of 2 to 14 days. This incubation period is longer than what most clinicians reflexively associate with foodborne illness, which tends to anchor thinking toward a 24 to 72 hour window. A patient reporting diarrhea that started a week or more after a specific meal, rather than the next day, shouldn't be dismissed as an unlikely connection.

The bigger clinical flag is duration. Unlike most viral gastroenteritis, which typically resolves within a few days, cyclosporiasis symptoms can persist for weeks, and in untreated or misdiagnosed cases, can relapse after apparent improvement. Any patient with watery diarrhea lasting more than a few days, particularly if it's not improving or is fluctuating, warrants specific consideration of Cyclospora, especially during the May through August cyclosporiasis season CDC tracks annually, and especially this year given the scale of the ongoing outbreak.

Why Standard Stool Testing Often Misses Cyclospora

This is the single most important operational point in this entire outbreak for practicing physicians, and it's explicitly called out in CDC's Health Alert Network notice.

A routine stool ova and parasite examination, run without a specific request for Cyclospora identification, frequently does not detect the organism. Cyclospora oocysts require a modified acid-fast stain or other specific microscopic technique to identify reliably, and that step isn't automatically included in a standard O&P workup unless it's specifically ordered or the lab's default protocol happens to include it.

Multiplex GI pathogen PCR panels add another layer of nuance. Some, but not all, commercial multiplex stool PCR panels include Cyclospora cayetanensis as one of their targets. A negative result on a broad GI panel doesn't necessarily rule out Cyclospora if the specific panel your lab uses doesn't test for it. This is worth confirming directly with your reference laboratory rather than assuming.

What this means practically

1. A "negative stool study" in a patient with a compatible clinical picture doesn't reliably exclude cyclosporiasis unless you know specifically what the test looked for.
2. If initial testing was negative but symptoms persist and the clinical picture still fits, it's reasonable to request Cyclospora-specific testing rather than assuming the diagnosis has been excluded.
3. This is exactly the kind of gap that leads to weeks of unresolved symptoms, unnecessary repeat visits, and a patient who eventually gets diagnosed much later than they should have been.

Ordering the Right Test

When cyclosporiasis is on the differential, be explicit with the lab about what you're looking for rather than ordering a generic stool study and assuming it's covered.

1. Request Cyclospora specifically, either through a modified acid-fast stained ova and parasite examination or a molecular test confirmed to include Cyclospora as a target.
2. If using a multiplex GI PCR panel, confirm with your laboratory whether Cyclospora cayetanensis is included among the panel's targets before relying on a negative result to exclude it.
3. Because the organism can be shed intermittently, a single negative specimen in a patient with a strongly compatible clinical picture doesn't necessarily rule out infection, and repeat testing or empiric treatment may be reasonable depending on clinical judgment.

Treatment

Cyclosporiasis is treatable, which makes accurate diagnosis all the more worthwhile. Trimethoprim-sulfamethoxazole is the standard first-line treatment. For patients with a documented sulfa allergy, alternative regimens should be discussed with an infectious disease specialist, since evidence for alternative agents is more limited.

Supportive care, including hydration, remains important throughout, particularly given how prolonged and volume-depleting the diarrhea associated with this infection can be, especially in older adults or patients with underlying health conditions, the same population that has accounted for the outbreak's more severe outcomes this year.

Coding and Reporting Cyclosporiasis Correctly

Getting the clinical diagnosis right is only part of the picture. Coding and reporting it correctly matters both for accurate reimbursement and for the broader public health response tracking this outbreak in real time.

Diagnosis coding

Cyclosporiasis has its own specific ICD-10-CM code, A07.3. Using this specific code rather than a general, unspecified intestinal infection code supports medical necessity for the specific testing ordered and gives a much clearer picture in the chart if the claim is reviewed.

Testing codes

Depending on the method your lab uses, stool testing for Cyclospora may be billed under ova and parasite examination codes, specific special stain codes for modified acid-fast staining, or, when using a molecular multiplex panel, the appropriate gastrointestinal pathogen panel code corresponding to the number of targets included. Because coding for stool parasitology and multiplex GI panels varies by method and by how many pathogens a specific panel tests for, confirm the exact CPT code with your laboratory or billing team based on the specific test performed, rather than assuming a single code applies universally.

Medical necessity documentation

Given that persistent, unresolved GI symptoms are what typically justify ordering a more specific or repeat stool study, documentation should clearly reflect symptom duration, any prior negative testing and what that testing did or didn't test for, and the clinical reasoning for pursuing Cyclospora-specific testing. This kind of documentation also supports prior authorization if a payer requires it for a more extensive multiplex panel.

Public health reporting

Because cyclosporiasis is a nationally notifiable disease in most states, confirmed cases generally need to be reported to your state or local health department, separate from any billing or claims process. During an active, high-profile outbreak like this one, timely reporting genuinely contributes to the broader investigation and source identification effort, beyond being a routine compliance requirement.

Common Mistakes Physicians Should Avoid

1. Assuming a standard stool ova and parasite exam automatically screens for Cyclospora without confirming the specific staining method used.
2. Ruling out cyclosporiasis based on a negative multiplex GI PCR panel without confirming Cyclospora was actually one of the panel's targets.
3. Anchoring on a short, one to three day incubation period and dismissing a patient's reported exposure because too much time had passed before symptoms began.
4. Treating persistent watery diarrhea as presumed viral gastroenteritis without reconsidering the diagnosis once symptoms extend beyond the typical viral course.
5. Coding the visit with a nonspecific gastrointestinal diagnosis code instead of A07.3 once cyclosporiasis is confirmed, which weakens the documentation trail and the public health data picture.
6. Forgetting to report a confirmed case to the state or local health department, since notifiable disease reporting is a separate obligation from clinical treatment and billing.

Actionable Tips for Practices During an Active Outbreak

1. Add Cyclospora to your standard differential for any patient presenting with watery diarrhea lasting more than a few days, particularly during the May through August season.
2. Confirm with your reference laboratory exactly which stool tests reliably detect Cyclospora, and whether your standard multiplex GI panel includes it as a target.
3. Build a brief standard question into GI intake covering recent consumption of raw produce, especially lettuce, leafy greens, herbs, and berries.
4. Use ICD-10 code A07.3 specifically once cyclosporiasis is confirmed, rather than a general intestinal infection code.
5. Confirm your practice's process for notifiable disease reporting to your state or local health department, and make sure front-line clinical staff know it's a separate step from ordering treatment.
6. Watch CDC's cyclosporiasis outbreak page for updated case counts and affected states, since the outbreak picture has been changing weekly.

Expert Recommendations

The clinical lesson from this outbreak isn't really about a rare or exotic pathogen. It's about the gap between what clinicians assume a "stool study" tests for and what a specific lab's default protocol actually includes. That gap exists in a normal year too, but this outbreak has made it a lot more consequential, given the sheer volume of patients now presenting with a genuinely elevated pretest probability of Cyclospora infection.

It's worth having a direct conversation with your reference laboratory now, not after the third patient with unexplained persistent diarrhea comes back with an unhelpful negative result. Knowing in advance exactly how to order Cyclospora-specific testing, and what your default panels do and don't cover, saves real time and prevents weeks of unresolved patient symptoms during an outbreak this size.

On the coding side, precision matters more than usual right now too. A wave of A07.3-coded visits, correctly documented, contributes real signal to the public health surveillance picture this outbreak depends on, beyond just supporting accurate reimbursement for your practice.

Frequently Asked Questions

How big is the 2026 Cyclospora outbreak?

Since May 1, 2026, the CDC has confirmed more than 15,700 laboratory-confirmed domestic cases, with thousands more under investigation, compared to roughly 1,180 cases in the same period in 2025. It is the largest known cyclosporiasis outbreak in U.S. history.

What caused the 2026 Cyclospora outbreak?

A significant portion of this year's cases have been linked to contaminated iceberg lettuce processed by Taylor Farms de Mexico, which was recalled on July 17, 2026. CDC and FDA are also investigating several other Cyclospora clusters unrelated to this specific lettuce outbreak.

What are the main symptoms of cyclosporiasis?

Watery diarrhea, often frequent and severe, along with loss of appetite, weight loss, bloating, nausea, and fatigue. Low-grade fever and vomiting occur less commonly.

How long after exposure do cyclosporiasis symptoms appear?

Symptoms typically begin about one week after exposure, with a documented range of 2 to 14 days, which is longer than the incubation period most clinicians associate with typical foodborne illness.

Why does standard stool testing sometimes miss Cyclospora?

Cyclospora oocysts require a modified acid-fast stain or other specific technique to identify reliably, which isn't automatically part of a routine stool ova and parasite exam unless specifically requested. Not all multiplex GI PCR panels include Cyclospora as a target either.

What's the treatment for cyclosporiasis?

Trimethoprim-sulfamethoxazole is the standard first-line treatment. Patients with a sulfa allergy should be evaluated for alternative regimens, ideally with infectious disease input given more limited evidence for alternatives.

Is cyclosporiasis contagious from person to person?

No. Cyclospora is not typically spread directly from person to person. It spreads through consuming food or water contaminated with the parasite.

What ICD-10 code should be used for a confirmed cyclosporiasis diagnosis?

ICD-10-CM code A07.3 is the specific code for cyclosporiasis and should be used instead of a general, unspecified intestinal infection code once the diagnosis is confirmed.

Do physicians need to report confirmed Cyclospora cases?

Yes, in most jurisdictions. Cyclosporiasis is a nationally notifiable disease, reportable in 47 states, the District of Columbia, and New York City, and reporting to the state or local health department is a separate obligation from clinical treatment and billing.

When does cyclosporiasis season typically occur?

CDC defines the annual cyclosporiasis season as May 1 through August 31, with cases historically peaking during the summer months, consistent with the pattern seen in this year's outbreak.

Conclusion

This year's cyclosporiasis outbreak is large enough, and persistent enough, that it deserves a place in the differential for any patient with unresolved watery diarrhea, not just patients with an obvious dietary link to the recalled lettuce. The clinical risk here isn't really about recognizing an unusual disease. It's about knowing that a negative stool study doesn't always mean what it appears to mean, and being specific about what you're asking your lab to test for. Getting that right, along with accurate coding and timely notifiable disease reporting, serves both the individual patient in front of you and the broader outbreak response happening at the same time.

Get Help With Coding and Documentation During Outbreak Season

Accurately diagnosing and treating cyclosporiasis is only half the equation. Getting the visit coded correctly, with the right ICD-10 code, appropriate testing documentation, and medical necessity support for specialized stool studies, protects both patient care continuity and your practice's reimbursement. Edge RCM works with primary care, urgent care, and gastroenterology practices on coding accuracy and documentation review for infectious disease and GI-related visits, including situations shaped by active public health outbreaks like this one. If your practice is seeing a rise in persistent GI presentations this season, Edge RCM can help make sure your coding keeps pace with what's actually happening in your exam rooms.